Neurisol (Gabapentin)

Gabapentin binds to the α2δ auxiliary subunit of voltage‑gated calcium channels in the central nervous system. This binding reduces calcium entry into neurons during depolarization, leading to a decreased release of excitatory neurotransmitters and, consequently, reduced neuronal hyper‑excitability and pain transmission.

The appropriate dose of Neurisol is individualized by the prescribing healthcare professional based on the patient’s condition, age, renal function and response to therapy. Dosage adjustments are made according to clinical guidelines and the prescriber’s judgment.

Data on gabapentin use during pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against possible risks and discuss them with the patient. If treatment is deemed necessary, close monitoring is recommended.

To place an order, submit an enquiry on the Neurisol product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

The primary alternative to gabapentin is pregabalin, another gabapentinoid with a similar mechanism but higher potency and different pharmacokinetics. Both agents treat neuropathic pain and seizures, yet dosing schedules, side‑effect profiles and cost considerations may influence the choice between them.

Neurisol should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure that it is out of reach of children.

Neurisol is taken orally, usually with a full glass of water. It can be taken with or without food, but consistency with meals may help reduce gastrointestinal discomfort. Tablets should be swallowed whole and not crushed or chewed unless specifically instructed by a clinician.

Serious adverse events include severe hypersensitivity reactions such as rash, Stevens‑Johnson syndrome, or anaphylaxis; significant mood changes like depression or suicidal thoughts; and respiratory depression, especially when combined with other central nervous system depressants. Prompt medical attention is required if any of these occur.

Neurisol is contraindicated in patients with known hypersensitivity to gabapentin or any of its excipients. Caution is advised for individuals with severe renal impairment, uncontrolled psychiatric conditions, or those taking medications that may cause dangerous additive CNS depression.